484 related articles for article (PubMed ID: 34518209)
41. Monitoring Wnt/β-Catenin Signaling in Skin.
Ku AT; Miao Q; Nguyen H
Methods Mol Biol; 2016; 1481():127-40. PubMed ID: 27590159
[TBL] [Abstract][Full Text] [Related]
42. Wnt signaling in adult intestinal stem cells and cancer.
Krausova M; Korinek V
Cell Signal; 2014 Mar; 26(3):570-9. PubMed ID: 24308963
[TBL] [Abstract][Full Text] [Related]
43. Wnt signaling in cancer.
Polakis P
Cold Spring Harb Perspect Biol; 2012 May; 4(5):. PubMed ID: 22438566
[TBL] [Abstract][Full Text] [Related]
44. Pan-cancer genomic amplifications underlie a WNT hyperactivation phenotype associated with stem cell-like features leading to poor prognosis.
Chang WH; Lai AG
Transl Res; 2019 Jun; 208():47-62. PubMed ID: 31028732
[TBL] [Abstract][Full Text] [Related]
45. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
Lee SK; Hwang JH; Choi KY
Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
[TBL] [Abstract][Full Text] [Related]
46. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
Front Immunol; 2020; 11():122. PubMed ID: 32132993
[TBL] [Abstract][Full Text] [Related]
47. Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2.
Yan R; Zhu H; Huang P; Yang M; Shen M; Pan Y; Zhang C; Zhou X; Li H; Ke X; Zhang W; Hao P; Qu Y
Cell Rep; 2022 Feb; 38(5):110319. PubMed ID: 35108540
[TBL] [Abstract][Full Text] [Related]
48. Overexpressed sFRP3 exerts an inhibitory effect on hepatocellular carcinoma via inactivation of the Wnt/β-catenin signaling pathway.
Fang L; Gao C; Bai RX; Wang HF; Du SY
Cancer Gene Ther; 2021 Aug; 28(7-8):875-891. PubMed ID: 32978504
[TBL] [Abstract][Full Text] [Related]
49. The multiple ways Wnt signaling contributes to acute leukemia pathogenesis.
Soares-Lima SC; Pombo-de-Oliveira MS; Carneiro FRG
J Leukoc Biol; 2020 Oct; 108(4):1081-1099. PubMed ID: 32573851
[TBL] [Abstract][Full Text] [Related]
50. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
[TBL] [Abstract][Full Text] [Related]
51. Targeting the Wnt pathway in cancer: the emerging role of Dickkopf-3.
Veeck J; Dahl E
Biochim Biophys Acta; 2012 Jan; 1825(1):18-28. PubMed ID: 21982838
[TBL] [Abstract][Full Text] [Related]
52. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
[TBL] [Abstract][Full Text] [Related]
53. New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway.
Ge YX; Wang CH; Hu FY; Pan LX; Min J; Niu KY; Zhang L; Li J; Xu T
J Cell Physiol; 2018 Jan; 233(1):79-87. PubMed ID: 28181235
[TBL] [Abstract][Full Text] [Related]
54. Wnt/Planar Cell Polarity Signaling: New Opportunities for Cancer Treatment.
Daulat AM; Borg JP
Trends Cancer; 2017 Feb; 3(2):113-125. PubMed ID: 28718442
[TBL] [Abstract][Full Text] [Related]
55. Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis.
Leibold J; Ruscetti M; Cao Z; Ho YJ; Baslan T; Zou M; Abida W; Feucht J; Han T; Barriga FM; Tsanov KM; Zamechek L; Kulick A; Amor C; Tian S; Rybczyk K; Salgado NR; Sánchez-Rivera FJ; Watson PA; de Stanchina E; Wilkinson JE; Dow LE; Abate-Shen C; Sawyers CL; Lowe SW
Cancer Discov; 2020 Jul; 10(7):1038-1057. PubMed ID: 32376773
[TBL] [Abstract][Full Text] [Related]
56. Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.
Chen J; Rajasekaran M; Hui KM
Exp Biol Med (Maywood); 2017 Jun; 242(11):1142-1149. PubMed ID: 28429652
[TBL] [Abstract][Full Text] [Related]
57. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
58. Addressing activation of WNT beta-catenin pathway in diverse landscape of endometrial carcinogenesis.
De P; Aske JC; Dale A; Rojas Espaillat L; Starks D; Dey N
Am J Transl Res; 2021; 13(11):12168-12180. PubMed ID: 34956444
[TBL] [Abstract][Full Text] [Related]
59. Wnt-Induced Stabilization of KDM4C Is Required for Wnt/β-Catenin Target Gene Expression and Glioblastoma Tumorigenesis.
Chen Y; Fang R; Yue C; Chang G; Li P; Guo Q; Wang J; Zhou A; Zhang S; Fuller GN; Shi X; Huang S
Cancer Res; 2020 Mar; 80(5):1049-1063. PubMed ID: 31888886
[TBL] [Abstract][Full Text] [Related]
60. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
